Literature DB >> 10828075

Transcriptional activation of JC virus by human T-lymphotropic virus type I Tax protein in human neuronal cell lines.

Y Okada1, H Sawa, S Tanaka, A Takada, S Suzuki, H Hasegawa, T Umemura, J Fujisawa, Y Tanaka, W W Hall, K Nagashima.   

Abstract

Polyomavirus JC (JCV) causes the human demyelinating disease, progressive multifocal leukoencephalopathy (PML). The recent demonstration of cases of PML in association with human T-lymphotropic virus type I (HTLV-I) infection prompted us to examine whether the HTLV-I-encoded regulatory protein Tax activates JCV transcription. By employing a dual luciferase assay, we initially found that the expression of Tax activated the transcriptional potential of both early and late promoters of JCV in human neuronal but not in non-neuronal cells. We subsequently analyzed the mechanism of Tax-induced activation of the JCV promoter in neuronal cells with the following results: 1) the JCV promoter that lacks the NF-kappaB-binding motif could not be activated by Tax; 2) the overexpression of IkappaBalpha abolished Tax-induced transcriptional activation of the JCV promoter; 3) a Tax mutant (M22) lacking the potential for activation via the NF-kappaB pathway did not activate the JCV promoter. Furthermore, Tax enhances the gene expression of JCV T antigen and VP1. We examined mechanisms of the cell-specific activation of the JCV promoter by Tax. Electrophoretic mobility shift assay demonstrated the presence of Tax-bound protein(s) that were specifically present in non-neuronal cells. This study is the first demonstration of the activation of JCV promoter by HTLV-I Tax in an NF-kappaB-dependent manner.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10828075     DOI: 10.1074/jbc.275.22.17016

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  7 in total

Review 1.  A classification scheme for human polyomavirus JCV variants based on the nucleotide sequence of the noncoding regulatory region.

Authors:  P N Jensen; E O Major
Journal:  J Neurovirol       Date:  2001-08       Impact factor: 2.643

2.  Microarray analysis of glial cells resistant to JCV infection suggests a correlation between viral infection and inflammatory cytokine gene expression.

Authors:  Kate Manley; Gretchen V Gee; Carl P Simkevich; John M Sedivy; Walter J Atwood
Journal:  Virology       Date:  2007-06-06       Impact factor: 3.616

3.  Oligosaccharides as receptors for JC virus.

Authors:  Rika Komagome; Hirofumi Sawa; Takashi Suzuki; Yasuo Suzuki; Shinya Tanaka; Walter J Atwood; Kazuo Nagashima
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

4.  NFAT4 is required for JC virus infection of glial cells.

Authors:  Kate Manley; Bethany A O'hara; Gretchen V Gee; Carl P Simkevich; John M Sedivy; Walter J Atwood
Journal:  J Virol       Date:  2006-10-11       Impact factor: 5.103

5.  Interferon beta1-a and selective anti-5HT(2a) receptor antagonists inhibit infection of human glial cells by JC virus.

Authors:  B A O'Hara; W J Atwood
Journal:  Virus Res       Date:  2008-03       Impact factor: 3.303

6.  Establishment of an immunoscreening system using recombinant VP1 protein for the isolation of a monoclonal antibody that blocks JC virus infection.

Authors:  Chizuka Henmi; Hirofumi Sawa; Hiroshi Iwata; Yasuko Orba; Shinya Tanaka; Kazuo Nagashima
Journal:  Biochem Biophys Res Commun       Date:  2005-02-04       Impact factor: 3.575

7.  Cysteine residues in the major capsid protein, Vp1, of the JC virus are important for protein stability and oligomer formation.

Authors:  Shintaro Kobayashi; Tadaki Suzuki; Manabu Igarashi; Yasuko Orba; Noriko Ohtake; Keita Nagakawa; Kenichi Niikura; Takashi Kimura; Harumi Kasamatsu; Hirofumi Sawa
Journal:  PLoS One       Date:  2013-10-09       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.